Committee for Medicinal Products for Human Use


Also found in: Acronyms, Wikipedia.

Committee for Medicinal Products for Human Use

The European Medicines Agency's committee, which is responsible for elaborating the agency's opinions on all issues regarding medicinal products for human use.
References in periodicals archive ?
It is the first opioid to be granted a positive opinion by the European Medicines Agency's Committee for Medicinal Products for Human Use.
The Committee for Medicinal Products for Human Use recommendation of OZURDEX is for diabetic macular edema patients who have an artificial lens implant, or who are considered otherwise unsuitable for non-corticosteroid therapy.
ST), a research-based pharmaceutical company, has received a positive opinion from the Committee for Medicinal Products for Human Use, recommending marketing authorisation in the EU for the use of simeprevir in combination with other medicinal products for the treatment of chronic hepatitis C in adult patients, it was reported yesterday.
GTC", Nasdaq: GTCB) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has adopted a positive opinion on the market authorization application (MAA) for ATryn(R), GTC's recombinant form of human antithrombin.
Teva Pharmaceutical, an Israel-based pharmaceutical company, has received positive opinion recommending marketing authorisation for DuoResp Spiromax (budesonide & formoterol fumarate dihydrate) inhalation powder from the European Medicines Agency's Committee for Medicinal Products for Human Use, it was reported yesterday.
The Committee for Medicinal Products for Human Use of the European Agency for the Evaluation of Medicinal Products issued a positive opinion recommending Thelin 100 milligram tablets as a once-daily oral treatment for patients with pulmonary arterial hypertension.
BioMarin Pharmaceutical, a United States-based pharmaceutical company, has received positive opinion for the marketing authorisation application for its drug, Vimizim (elosulfase alfa), from the European Medicines Agency's Committee for Medicinal Products for Human Use, it was reported on Friday.
and DUBLIN, Ireland -- Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) announced today that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMEA), issued a positive opinion recommending marketing authorization for TYSABRI(R) (natalizumab) as a treatment for relapsing-remitting multiple sclerosis (MS) to delay the progression of disability and reduce the frequency of relapses.
M2 PHARMA-December 24, 2013-Roche receives positive opinion for RoACTEMRA from European Medicines Agency's Committee for Medicinal Products for Human Use
NYSE:AGN) today announced that the Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission approve GANFORT(R), Allergan's LUMIGAN(R)/timolol combination product (bimatoprost/timolol ophthalmic solution) for the treatment of glaucoma.
Actelion, a biopharmaceutical company, has received positive opinion for the use of Opsumit (macitentan) 10mg for the treatment of pulmonary arterial hypertension, from the Committee for Medicinal Products for Human Use, the scientific committee of the European Medicines Agency.
GTC", Nasdaq: GTCB) announced today that it has been told that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) intends to issue a negative opinion on the market authorization application (MAA) for ATryn(R), GTC's recombinant form of human antithrombin.
Full browser ?